PATENT CLAIM ANALYSIS

Application Number: 16068257
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "470000"]

Abstract:
Disclosed is the use of an active ingredient in the manufacture of a medicament, wherein the active ingredient is selected from the group consisting of butylidenephthalide (BP), a pharmaceutically acceptable salt of butylidenephthalide, and combinations thereof, and wherein the medicament is used for the prevention and/or treatment of oral submucous fibrosis (OSF) and may be used in the form of an injection lozenge, oral solution, or smearing preparation.

Claim (Index 13):
The method as claimed in  claim 2 , wherein the active ingredient is administered as an injection, a tablet, an oral liquid, or a smearing preparation.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 1.68085
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15593910', '13112220', '14520050', '13109619', '13331059']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7158203021077079
- 35 USC 102 Novelty (BERT): 0.5077667938187785
- Combined Prediction Score: 0.6950149512788149
- Mean Citation Score: 164.80742800000004
- Max Citation Score: 190.96313
- Similarity Product: 118.2833982913214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test